vTv Therapeutics Inc. (VTVT): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of VTVT were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling vTv Therapeutics
From the latest filingsOverall: more buying than selling. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns VTVT
44 funds and institutions reported VTVT shares worth $60.5M at the end of Q2 2026. The largest holder is Samsara Biocapital, LLC with $11.2M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Samsara Biocapital, LLC | 298,496 | – | $11.2M | No change |
| Millennium Management LLC | 269,874 | – | $10.2M | +31% |
| FMR LLC (Fidelity) | 260,391 | – | $9.8M | No change |
| Siren, L.L.C. | 163,000 | – | $6.1M | No change |
| Baker Bros. Advisors LP | 148,314 | – | $5.6M | No change |
| Vanguard Capital Management LLC | 94,463 | – | $3.6M | -13% |
| Trails Edge Capital Partners, LP | 85,192 | – | $3.2M | -39% |
| Aisling Capital Management LP | 50,000 | – | $1.9M | New |
| Marshall Wace, LLP | 39,560 | – | $1.5M | +195% |
| Geode Capital Management, LLC | 32,470 | – | $1.2M | -1% |
| Renaissance Technologies LLC | 17,454 | – | $657K | New |
| Vanguard Fiduciary Trust Co | 16,239 | – | $611K | +1% |
| BlackRock, Inc. | 14,731 | – | $555K | +17% |
| Jane Street Group, LLC | 13,703 | – | $516K | New |
| State Street Corp | 12,266 | – | $462K | +15% |
| Two Sigma Investments, LP | 11,486 | – | $432K | New |
| Verdad Advisers, LP | 8,996 | – | $339K | New |
| Integrated Quantitative Investments LLC | 8,210 | – | $309K | New |
| Susquehanna International Group, LLP | 8,023 | – | $302K | New |
| Quadrature Capital Ltd | 6,305 | – | $237K | New |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No VTVT insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
VTVT short interest
145,417 VTVT shares are sold short. Over the last 12 reports the number of shares short went up 1%.
As of Oct 30, 2026, 145,417 VTVT shares were sold short, up 1.4% from the report before. At the average daily volume of 17,705 shares, buying them all back would take about 8.2 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 145,417 | – | +1% | 17,705 | 8.2 |
| Oct 15, 2026 | 143,400 | – | -9% | 25,253 | 5.7 |
| Sep 30, 2026 | 156,754 | – | -2% | 47,562 | 3.3 |
| Sep 15, 2026 | 160,312 | – | -2% | 31,782 | 5.0 |
| Aug 31, 2026 | 162,908 | – | -2% | 59,666 | 2.7 |
| Aug 14, 2026 | 166,003 | – | +0% | 105,098 | 1.6 |
| Jul 31, 2026 | 165,792 | – | -4% | 112,289 | 1.5 |
| Jul 15, 2026 | 172,198 | – | +5% | 60,918 | 2.8 |
| Jun 30, 2026 | 163,681 | – | +3% | 70,443 | 2.3 |
| Jun 15, 2026 | 158,523 | – | +1% | 33,778 | 4.7 |
| May 29, 2026 | 157,260 | – | +9% | 44,849 | 3.5 |
| May 15, 2026 | 144,573 | – | +6% | 39,885 | 3.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
vTv Therapeutics company events
vTv Therapeutics filed 11 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Oct 6, 2026RulesChanged its bylaws or articles. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jun 29, 2026VoteReported shareholder vote results. Filing
- May 13, 2026AnnouncementVTv Therapeutics Inc. filed a prospectus supplement with the SEC to increase the number of shares of Class A common stock offered under its previously-announced at-the-market sales program to the full amount provided for under the ATM program. Filing
- May 13, 2026ResultsReleased financial results. Filing
- Mar 10, 2026AnnouncementShared information with investors. Filing
- Mar 10, 2026ResultsReleased financial results. Filing
- Feb 26, 2026AnnouncementShared information with investors. Filing
- Feb 2, 2026AgreementVTv Therapeutics LLC, a subsidiary of vTv Therapeutics Inc., entered into the Second Amendment to License Agreement with Newsoara Biopharma Co., Ltd. to amend the License Agreement previously entered into between vTv LLC and Newsoara on May 31, 2018 . Although the Company had previously entered… Filing
- Dec 19, 2025RulesChanged its bylaws or articles. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
vTv Therapeutics financials
Famous investors that hold VTVT
2 of the 50 well-known investors we track reported holding VTVT in their latest 13F filing. The largest position is Israel Englander's, worth $10.6M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 342,481 | $10.6M | 0.0% | +27% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 21,306 | $657K | 0.0% | +22% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named VTVT in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Samsara BioCapital, L.P. | 13D/A | 6.1% |
| Nov 16, 2026 | Samsara BioCapital, L.P. | 13D/A | 6.1% |
| Oct 8, 2026 | Integrated Core Strategies (US) LLC | 13G/A | 7.9% |
| Oct 8, 2026 | Integrated Core Strategies (US) LLC | 13G/A | 7.9% |
Questions about vTv Therapeutics Inc. (VTVT) stock
Who owns the most VTVT stock?
The largest reported owner of vTv Therapeutics Inc. (VTVT) is Samsara Biocapital, LLC. In total, 44 funds and institutions reported holding VTVT at the end of Q2 2026. See the largest owners.
Are VTVT insiders buying or selling?
No VTVT insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in VTVT?
As of Oct 30, 2026, 145,417 VTVT shares were sold short, up 1.4% from the report before. At the average daily volume of 17,705 shares, buying them all back would take about 8.2 trading days (days to cover). See the history.
Which famous investors hold VTVT?
2 of the 50 well-known investors we track reported VTVT in their latest 13F filing, including Israel Englander, Jim Simons. The largest position is worth $10.6M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.